Trial Profile
Clinical Study on rapid-acting insulin analog in intensive basal and bolus insulin therapy - Efficacy and safety of glulisine-based multiple daily injection therapy in Japanese diabetic patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 16 May 2013
Price :
$35
*
At a glance
- Drugs Insulin glulisine (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Adverse reactions; Biomarker; Pharmacodynamics; Therapeutic Use
- 16 May 2013 New trial record